Distinct contribution of PD-L1 suppression by spatial expression of PD-L1 on tumor and non-tumor cells

Programmed cell death receptor 1 (PD-1) and its ligand, PD-L1, are important immune checkpoint proteins. Although antibodies that block PD-1/PD-L1 have shown promising clinical efficacy in a subset of cancer patients, the detailed cellular and molecular mechanisms behind anti-PD-1 and anti-PD-L1 imm...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cell Mol Immunol
Egile Nagusiak: Zhang, Xiaoqing, Cheng, Chen, Hou, Jiyan, Qi, Xinyue, Wang, Xin, Han, Ping, Yang, Xuanming
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Publishing Group UK 2018
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6461875/
https://ncbi.nlm.nih.gov/pubmed/29568117
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41423-018-0021-3
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak